Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Sex Med. 2019 Jan 14;16(2):235–247. doi: 10.1016/j.jsxm.2018.12.007

Table 4.

Results of Cross-Sectional Unadjusted and Adjusted Logistic Regression Analyses Examining Associations between Blood Pressure and Sexual Activity

Unadjusted Model
n=1254
Adjusted Model
n=1198
Characteristic Odds Ratio (95% CI) P value Odds Ratio (95% CI) P value
Unadjusted Model
Systolic Blood Pressure (per 5 mmHg increase) 0.98 (0.97,0.99) <.0001 0.998 (0.99, 1.01) 0.70
Diastolic Blood Pressure (per 5 mmHg increase) 1.04 (1.03, 1.05) <.0001 1.001 (0.98, 1.02) 0.92
Demographic Variables
Age (yrs). --- --- 0.9494 (0.93, 0.96) <.0001
African-American vs. White --- --- 1.34 (0.91, 1.96) 0.14
Hispanic vs. White 0.70 (0.45, 1.11) 0.13
Other vs. White --- --- 1.07 (0.35, 3.23) 0.91
< High school vs. College Graduate --- --- 0.56 (0.33, 0.98) 0.043
High School graduate/GED vs. College Graduate --- --- 0.64 (0.43, 0.96) 0.031
Post High School vs. College Graduate --- --- 1.01 (0.73, 1.40) 0.95
Lives with Others vs. Lives Alone --- --- 1.57 (1.16, 2.13) 0.004
Behavioral Risk Factor and Medication Use Variables
Pack-years of Smoking --- --- 1.00 (0.99, 1.01) 0.57
Alcohol Consumption (drinks/typical wk) --- --- 1.06 (0.97, 1.20) 0.20
Beta-blockers (BB) vs. no BB --- --- 1.17 (0.86, 1.58) 0.32
Diuretics vs. No Diuretics --- --- 0.81 (0.61, 1.06) 0.13
Calcium Channel Blockers vs.no Calcium Channel Blockers --- --- 0.96 (0.72, 1.27) 0.78
Angiotensin Receptor Blockers (ARB) vs. no ARB --- --- 1.16 (0.86, 1.55) 0.33
Angiotensin Converting Enzyme (ACE) Inhibitors vs. no ACE 1.13 (0.77, 1.65) 0.53
Any Cholesterol Medication --- --- 1.00 (0.75, 1.34) 0.98
Any Phosphodiesterase Type 5 Inhibitors --- --- 3.70 (2.11, 6.48) <.0001
Cardiometabolic and Psychosocial Variables
BMI (kg/m2) --- --- 1.00 (0.98, 1.03) 0.76
eGFR (mL/min/1.73 m2) --- --- 1.00 (0.99, 1.01) 0.54
MoCA Total Score a --- --- 1.03 (0.99, 1.08) 0.15
PHQ-9 Total Score b --- --- 0.96 (0.93, 1.00) 0.027
Number of Physical Comorbidities b --- --- 0.93 (0.88, 0.99) 0.015

--- variable not included in model

significant (p<0.05) Adjusted Odds Ratios and 95% Confidence Intervals presented in bold

a

Higher scores indicate better function

b

Higher scores indicate poorer function